Status:
COMPLETED
Studies of Immune Responses in Patients With Chronic Hepatitis B
Lead Sponsor:
National Taiwan University Hospital
Conditions:
Hepatitis B
Eligibility:
All Genders
Brief Summary
Taiwan is a hyperendemic area of hepatitis B virus (HBV) infection. Previous studies demonstrated vigorous T cell responses to HBV-encoded antigens developed in patients with self-limited acute hepati...
Detailed Description
The HBsAg (+) patients from National Taiwan University Hospital will be included. Screening for HLA haplotype will be performed by amplification refractory mutation system / PCR method. The HLA-A2 or ...
Eligibility Criteria
Inclusion
- patients chronically infected with hepatitis B virus
Exclusion
- coinfected with HCV or HIV
Key Trial Info
Start Date :
May 1 2005
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT00155155
Start Date
May 1 2005
Last Update
December 2 2008
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
National Taiwan University Hospital
Taipei, Taiwan, 100